Zydus Cadila
Zydus Cadila gets USFDA nod for multiple sclerosis treatment drug
Zydus Cadila gets tentative USFDA approval to market anti-cancer drug
Zydus Cadila gets USFDA nod to market mineral supplement tablets
India's Covid-19 tally nears 5 mn with one-fifth of total cases active
Zydus Cadila gets USFDA nod to market its cancer treatment injection

Zydus Cadila gets tentative US FDA approval for generic diabetes drug
Zydus Cadila gets approval from USFDA for muscle relaxant injection
Zydus Wellness board approves fund-raising of up to Rs 1,100 crore
Covid-19: At Rs 2,800 per dose, Zydus launches cheapest remdesivir brand
Zydus Cadila gets USFDA nod to market phosphorus controlling drug

Zydus launches cheapest remdesivir at Rs 2,800 per 100 mg vial in India
Zydus Cadila launches India's 'cheapest' remdesivir at Rs 2,800 per vial
Zydus Cadila to begin phase II Covid-19 vaccine clinical trials from Aug 6
Zydus Cadila gets tentative USFDA nod to market Parkinson's disease drug
Zydus gets USFDA nod for drug trials to treat chemotherapy-induced anemia
Zydus Cadila gets USFDA nod to market generic drug to treat headache
Zydus gets nod from Mexican authority for Covid-19 therapy clinical trials
Human trials of Covid-19 vaccine a milestone for Atmanirbhar Bharat: DBT
Zydus Cadila begins human trials for its Covid-19 vaccine candidate
Zydus gets Mexican regulator's approval for coronavirus drug study